Display options
Cite
Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31doi: 10.1186/1478-811X-8-31.
Chaitanya, G. V., Steven, A. J., & Babu, P. P. (2010). PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell communication and signaling : CCS, 831. https://doi.org/10.1186/1478-811X-8-31
Chaitanya, Ganta Vijay, et al. "PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration." Cell communication and signaling : CCS vol. 8 (2010): 31. doi: https://doi.org/10.1186/1478-811X-8-31
Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010 Dec 22;8:31. doi: 10.1186/1478-811X-8-31. PMID: 21176168; PMCID: PMC3022541.
Copy Download .nbib Format: NLM
Share it on

Cell Commun Signal. 2010 Dec 22;8:31. doi: 10.1186/1478-811X-8-31.

PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration.

Cell communication and signaling : CCS

Ganta Vijay Chaitanya, Alexander J Steven, Phanithi Prakash Babu

Affiliations

  1. Department of Biotechnology, School of Life Sciences, University of Hyderabad, Hyderabad, India. [email protected].

PMID: 21176168 PMCID: PMC3022541 DOI: 10.1186/1478-811X-8-31

Abstract

The normal function of poly (ADP-ribose) polymerase-1 (PARP-1) is the routine repair of DNA damage by adding poly (ADP ribose) polymers in response to a variety of cellular stresses. Recently, it has become widely appreciated that PARP-1 also participates in diverse physiological and pathological functions from cell survival to several forms of cell death and has been implicated in gene transcription, immune responses, inflammation, learning, memory, synaptic functions, angiogenesis and aging. In the CNS, PARP inhibition attenuates injury in pathologies like cerebral ischemia, trauma and excitotoxicity demonstrating a central role of PARP-1 in these pathologies. PARP-1 is also a preferred substrate for several 'suicidal' proteases and the proteolytic action of suicidal proteases (caspases, calpains, cathepsins, granzymes and matrix metalloproteinases (MMPs)) on PARP-1 produces several specific proteolytic cleavage fragments with different molecular weights. These PARP-1 signature fragments are recognized biomarkers for specific patterns of protease activity in unique cell death programs. This review focuses on specific suicidal proteases active towards PARP-1 to generate signature PARP-1 fragments that can identify key proteases and particular forms of cell death involved in pathophysiology. The roles played by some of the PARP-1 fragments and their associated binding partners in the control of different forms of cell death are also discussed.

References

  1. Biol Chem. 1999 Jul-Aug;380(7-8):953-9 - PubMed
  2. Biochem Biophys Res Commun. 1996 Dec 4;229(1):193-7 - PubMed
  3. Cancer Res. 1998 Aug 15;58(16):3495-8 - PubMed
  4. Biochem J. 1999 Sep 1;342 ( Pt 2):249-68 - PubMed
  5. Inflammation. 2001 Jun;25(3):157-63 - PubMed
  6. Annu Rev Genet. 2009;43:67-93 - PubMed
  7. Mol Cell Biochem. 2009 Feb;322(1-2):53-62 - PubMed
  8. CNS Neurol Disord Drug Targets. 2008 Jun;7(3):305-12 - PubMed
  9. EMBO Rep. 2006 Apr;7(4):431-7 - PubMed
  10. Biochim Biophys Acta. 1997 Mar 7;1338(1):100-6 - PubMed
  11. J Cell Sci. 2001 Oct;114(Pt 20):3771-8 - PubMed
  12. Neuropathology. 2005 Mar;25(1):48-53 - PubMed
  13. Cell. 2008 May 16;133(4):681-92 - PubMed
  14. J Neurosci. 2009 Jul 29;29(30):9553-62 - PubMed
  15. Curr Biol. 2006 Aug 22;16(16):1606-15 - PubMed
  16. Biochem Biophys Res Commun. 1996 Oct 23;227(3):658-65 - PubMed
  17. Neuroscience. 2010 Feb 17;165(4):1203-16 - PubMed
  18. Clin Cancer Res. 2009 Oct 1;15(19):6042-51 - PubMed
  19. Biochemistry. 1997 Oct 7;36(40):12147-54 - PubMed
  20. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5746-51 - PubMed
  21. J Rheumatol. 2008 Oct;35(10):1932-43 - PubMed
  22. Dev Cell. 2008 Mar;14(3):399-410 - PubMed
  23. Neurol India. 2009 May-Jun;57(3):264-8 - PubMed
  24. Cell Death Differ. 2008 Jul;15(7):1139-46 - PubMed
  25. Am J Physiol Cell Physiol. 2001 Oct;281(4):C1096-105 - PubMed
  26. Methods Enzymol. 2008;442:183-99 - PubMed
  27. J Physiol. 2007 Dec 15;585(Pt 3):741-58 - PubMed
  28. Transplantation. 1994 Apr 27;57(8):1289-92 - PubMed
  29. Exp Neurol. 2009 Jul;218(1):75-82 - PubMed
  30. Annu Rev Pharmacol Toxicol. 2004;44:349-70 - PubMed
  31. BMC Dev Biol. 2006 Jan 24;6:3 - PubMed
  32. J Biol Chem. 1997 Mar 14;272(11):7223-8 - PubMed
  33. Mol Biol Biochem Biophys. 1987;37:1-237 - PubMed
  34. Vascular. 2006 Nov-Dec;14(6):362-5 - PubMed
  35. Int J Cancer. 2009 Dec 15;125(12):2757-66 - PubMed
  36. Nature. 2004 Dec 2;432(7017):645-9 - PubMed
  37. Trends Mol Med. 2001 Aug;7(8):355-62 - PubMed
  38. J Alzheimers Dis. 2009;18(4):843-8 - PubMed
  39. Exp Neurol. 2009 Aug;218(2):213-20 - PubMed
  40. Mol Neurobiol. 2001 Aug-Dec;24(1-3):131-44 - PubMed
  41. Biochem Biophys Res Commun. 2009 Oct 2;387(4):646-50 - PubMed
  42. J Biol Chem. 1988 Mar 15;263(8):3879-83 - PubMed
  43. Neurochem Res. 2008 Jun;33(6):1117-28 - PubMed
  44. FASEB J. 2004 Apr;18(6):690-2 - PubMed
  45. Mol Cell Biol. 2007 Nov;27(21):7475-85 - PubMed
  46. Nature. 1994 Sep 22;371(6495):346-7 - PubMed
  47. J Mol Med (Berl). 2004 Jun;82(6):389-97 - PubMed
  48. Tissue Antigens. 2008 May;71(5):409-16 - PubMed
  49. Bioessays. 2004 Aug;26(8):882-93 - PubMed
  50. Mutat Res. 2001 Jun 2;477(1-2):97-110 - PubMed
  51. J Biol Chem. 2001 Nov 16;276(46):43285-93 - PubMed
  52. Cell. 2003 Jun 13;113(6):677-83 - PubMed
  53. J Biol Chem. 1999 Nov 5;274(45):32122-6 - PubMed
  54. J Cereb Blood Flow Metab. 2004 Oct;24(10):1133-45 - PubMed
  55. Mol Cell Biol. 2007 Aug;27(15):5597-605 - PubMed
  56. J Cell Biol. 2006 Apr 24;173(2):231-9 - PubMed
  57. J Biol Chem. 1999 Oct 1;274(40):28379-84 - PubMed
  58. Cell Death Differ. 2001 Jun;8(6):588-94 - PubMed
  59. Bioessays. 2004 Dec;26(12):1268-71 - PubMed
  60. Biochem Pharmacol. 2008 Jan 15;75(2):346-59 - PubMed
  61. Biochemistry. 2004 Jan 13;43(1):210-6 - PubMed
  62. Biochem Pharmacol. 2005 Mar 1;69(5):725-32 - PubMed
  63. Cell Mol Neurobiol. 2009 Jun;29(4):563-73 - PubMed
  64. FASEB J. 2006 Jun;20(8):1209-11 - PubMed
  65. Cell Mol Life Sci. 2005 Apr;62(7-8):760-8 - PubMed
  66. FEBS Lett. 1998 Aug 14;433(1-2):1-4 - PubMed
  67. Science. 2009 Aug 14;325(5942):834-40 - PubMed
  68. Trends Pharmacol Sci. 2007 Nov;28(11):556-60 - PubMed
  69. Genome Biol. 2001;2(12):REVIEWS3014 - PubMed
  70. J Biol Chem. 2005 Feb 11;280(6):4663-73 - PubMed
  71. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11274-9 - PubMed
  72. Cell Death Differ. 2008 Jul;15(7):1113-23 - PubMed
  73. J Neurosci Res. 1998 Oct 15;54(2):223-32 - PubMed
  74. Mol Biol Cell. 2002 Mar;13(3):978-88 - PubMed
  75. Arthritis Rheum. 2005 Jan;52(1):201-11 - PubMed
  76. Blood. 2006 Oct 1;108(7):2290-9 - PubMed
  77. Arthritis Rheum. 2005 Jul;52(7):2133-45 - PubMed
  78. Mol Cell Biol. 1999 Jul;19(7):5124-33 - PubMed
  79. BMC Genomics. 2007 Feb 07;8:41 - PubMed
  80. Mol Cell Biol. 2006 Oct;26(19):7258-68 - PubMed
  81. J Neurochem. 2003 Apr;85(2):306-17 - PubMed
  82. J Biol Chem. 2004 Dec 31;279(53):55117-26 - PubMed
  83. Neurochem Int. 2006 Jan;48(2):108-13 - PubMed
  84. Int J Biochem Cell Biol. 2005 May;37(5):1043-53 - PubMed
  85. Front Biosci (Landmark Ed). 2009 Jan 01;14:2358-71 - PubMed
  86. Nucleic Acids Res. 2003 Oct 1;31(19):5526-33 - PubMed
  87. Biochem Biophys Res Commun. 2006 Nov 17;350(2):352-7 - PubMed
  88. Free Radic Biol Med. 2006 Nov 15;41(10):1578-89 - PubMed
  89. Int J Biochem Cell Biol. 2004 Feb;36(2):223-34 - PubMed
  90. J Pharmacol Exp Ther. 2005 Mar;312(3):891-8 - PubMed
  91. J Neurochem. 2008 Jul;106(2):578-90 - PubMed
  92. J Biol Chem. 2008 Feb 15;283(7):4105-14 - PubMed
  93. J Biol Chem. 2000 Jan 7;275(1):82-6 - PubMed
  94. J Cell Sci. 2005 Sep 1;118(Pt 17):3829-38 - PubMed
  95. J Neurosci. 2006 Nov 8;26(45):11540-53 - PubMed
  96. Neuroscience. 2009 Feb 6;158(3):983-94 - PubMed
  97. Brain Res Mol Brain Res. 2002 Jul 15;104(1):55-65 - PubMed
  98. Genes Dev. 1995 Mar 1;9(5):509-20 - PubMed
  99. Mol Neurobiol. 2006 Jun;33(3):215-36 - PubMed
  100. Cancer Res. 1997 May 15;57(10):1835-40 - PubMed
  101. Cell. 1995 Jun 2;81(5):801-9 - PubMed
  102. Immunol Cell Biol. 2006 Feb;84(1):72-8 - PubMed
  103. Cancer Res. 1993 Sep 1;53(17):3976-85 - PubMed
  104. FASEB J. 2006 Jul;20(9):1443-51 - PubMed
  105. Biochimie. 1999 Jan-Feb;81(1-2):69-75 - PubMed
  106. Oncogene. 2008 Oct 20;27(48):6194-206 - PubMed
  107. J Mol Biol. 2005 May 6;348(3):609-15 - PubMed
  108. Nat Rev Mol Cell Biol. 2009 Sep;10(9):623-35 - PubMed
  109. J Cell Biol. 2005 Feb 14;168(4):545-51 - PubMed
  110. Exp Cell Res. 2001 Oct 1;269(2):193-201 - PubMed
  111. J Neurosci. 2003 Jun 15;23(12):5020-30 - PubMed
  112. Mol Cell Biol. 1998 Jun;18(6):3563-71 - PubMed
  113. Mol Cell. 2007 Jan 26;25(2):297-308 - PubMed
  114. Subcell Biochem. 2007;45:465-80 - PubMed
  115. Nat Rev Cancer. 2009 Jul;9(7):501-7 - PubMed
  116. Blood. 2009 Aug 6;114(6):1205-16 - PubMed
  117. Am J Transplant. 2005 Mar;5(3):494-9 - PubMed
  118. Cancer Lett. 2010 Feb 28;288(2):162-9 - PubMed
  119. Nucleic Acids Res. 2006;34(21):6170-82 - PubMed
  120. Cardiovasc Diabetol. 2009 Sep 14;8:50 - PubMed
  121. Cell Mol Immunol. 2009 Feb;6(1):15-25 - PubMed
  122. J Biol Chem. 1980 Nov 10;255(21):10502-8 - PubMed
  123. Med Sci (Paris). 2008 Nov;24(11):901-3 - PubMed
  124. J Biol Chem. 2006 Nov 3;281(44):33684-96 - PubMed
  125. FASEB J. 2001 Jun;15(8):1460-2 - PubMed
  126. Exp Neurol. 2003 Nov;184(1):359-72 - PubMed
  127. Mod Pathol. 2003 May;16(5):460-70 - PubMed
  128. J Neurosci Res. 2003 Sep 15;73(6):853-64 - PubMed
  129. Biochemistry (Mosc). 2003 Nov;68(11):1171-80 - PubMed
  130. Biochemistry. 2000 Jun 27;39(25):7559-69 - PubMed
  131. Brain. 2001 Mar;124(Pt 3):493-8 - PubMed
  132. Mol Neurobiol. 2008 Aug;38(1):27-65 - PubMed
  133. Mol Pharmacol. 1999 Oct;56(4):824-33 - PubMed
  134. Int J Biochem Cell Biol. 2006;38(4):662-70 - PubMed
  135. Riv Biol. 2007 Sep-Dec;100(3):351-60 - PubMed
  136. J Ocul Pharmacol Ther. 2009 Oct;25(5):409-14 - PubMed
  137. Cell Mol Life Sci. 2002 Sep;59(9):1534-53 - PubMed
  138. Cell Death Differ. 2003 Jan;10(1):76-100 - PubMed
  139. Cardiovasc Res. 2008 Apr 1;78(1):158-66 - PubMed
  140. Trends Neurosci. 2000 Jan;23(1):20-6 - PubMed
  141. J Biol Chem. 2003 Apr 18;278(16):14162-7 - PubMed
  142. Autophagy. 2008 Aug;4(6):762-9 - PubMed
  143. Cell Mol Life Sci. 2009 Apr;66(8):1419-33 - PubMed
  144. FEBS Lett. 1996 Aug 19;392(1):11-5 - PubMed
  145. Mol Med. 2003 May-Aug;9(5-8):143-53 - PubMed
  146. DNA Repair (Amst). 2008 Jul 1;7(7):1077-86 - PubMed
  147. J Neurosci. 2006 May 31;26(22):5996-6003 - PubMed
  148. Mol Cell Biol. 2008 May;28(9):2860-71 - PubMed
  149. Oncogene. 2003 Nov 20;22(52):8460-71 - PubMed
  150. Neurochem Res. 2008 Nov;33(11):2178-86 - PubMed
  151. FEBS Lett. 1998 Mar 27;425(2):266-70 - PubMed
  152. Neurobiol Aging. 2011 Dec;32(12):2190-7 - PubMed
  153. Nucleic Acids Res. 2004 Feb 02;32(2):669-80 - PubMed
  154. J Biol Chem. 2009 Sep 11;284(37):25441-9 - PubMed
  155. Biochem Biophys Res Commun. 1999 Sep 16;263(1):94-9 - PubMed
  156. Trends Cell Biol. 2008 Oct;18(10):467-73 - PubMed
  157. Mol Cell Biol. 2007 Dec;27(24):8454-65 - PubMed
  158. Curr Opin Immunol. 2003 Oct;15(5):533-43 - PubMed
  159. Neuropathology. 2009 Jun;29(3):270-9 - PubMed

Publication Types